Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sonavex

Sonavex
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A1 LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
24 INVESTORS
Description

Developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.

Website
Formerly Known As
Veridian Surgical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 2835 O'Donnell Street
  • Suite 200
  • Baltimore, MD 21224
  • United States

+1 (443) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sonavex’s full profile, request a free trial.

Sonavex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series A1) 05-Nov-2019 $3M 00.000 0000 Completed Generating Revenue
11. Grant 29-Aug-2019 000 00.000 Completed Generating Revenue
10. Early Stage VC (Series A) 01-Dec-2017 00.00 00.000 000.00 Completed Generating Revenue
9. Accelerator/Incubator 07-Aug-2017 00000 Completed Generating Revenue
8. Grant 24-Apr-2017 00000 00000 Completed Generating Revenue
7. Grant 01-May-2016 00000 00000 Completed Generating Revenue
6. Seed Round 19-Sep-2015 00000 00000 00.000 Completed Generating Revenue
5. Grant 06-Sep-2015 00000 Completed Generating Revenue
4. Grant 30-Jun-2015 $180K Completed Generating Revenue
3. Accelerator/Incubator 12-Dec-2014 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Sonavex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-1 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 140,464 $0.000100 $2.37 $2.37 1x $2.37 6.7%
To view this company’s complete Cap Table, request access »

Sonavex Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xoran Technologies Private Equity-Backed Ann Arbor, MI 00 000 0000000 0000 000
00000 0000000 Venture Capital-Backed Markham, Canada 00 000.00 0000000000 0 000.00
0000000000 0000000 Corporate Backed or Acquired Brønshøj, Denmark 0000 000000&0
To view this company’s complete list of competitors, request access »

Sonavex Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ChinaRock Capital Management Venture Capital Minority 000 0000 000000 0
FundRx Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
Grey Sky Venture Partners Venture Capital Minority 000 0000 000000 0
Houston Angel Network Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »

Sonavex Executive Team (5)

Name Title Board
Seat
Contact
Info
David Narrow Co-Founder, Chief Executive Officer & Board Member
Devin O'Brien-Coon MD Co-Founder, President, Chief Medical Officer & Chairman
Xin Kang Ph.D Director, Research & Development
Jerry Prince Ph.D Co-Founder & Board Member

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Sonavex Board Members (5)

Name Representing Role Since Contact
Info
Bob Hallenbeck Self Board Member 000 0000
David Narrow Sonavex Co-Founder, Chief Executive Officer & Board Member 000 0000
Devin O'Brien-Coon MD Sonavex Co-Founder, President, Chief Medical Officer & Chairman 000 0000
Jerry Prince Ph.D Self Co-Founder & Board Member 000 0000
William Niland Self Board Member 000 0000